The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update

Current research indicates that the next silent epidemic will be linked to chronic liver diseases, specifically non-alcoholic fatty liver disease (NAFLD), which was renamed as metabolic-associated fatty liver disease (MAFLD) in 2020. Globally, MAFLD mortality is on the rise. The etiology of MAFLD is...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou Assi, Reem, Abdulbaqi, Ibrahim M., Siok Yee, Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001129/
https://www.ncbi.nlm.nih.gov/pubmed/33806527
http://dx.doi.org/10.3390/ph14030215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001129/
https://www.ncbi.nlm.nih.gov/pubmed/33806527
http://dx.doi.org/10.3390/ph14030215

Ejemplares similares